{"id":40823,"date":"2021-08-12T18:45:00","date_gmt":"2021-08-12T11:45:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2021081218450040823"},"modified":"2021-08-12T21:37:50","modified_gmt":"2021-08-12T13:37:50","slug":"%e5%a4%a9%e6%bc%94%e8%8d%af%e4%b8%9a%e5%ae%a3%e5%b8%83%e4%bb%bb%e5%91%bd%e4%bb%a3%e7%90%86%e9%a6%96%e5%b8%ad%e5%8c%bb%e5%ad%a6%e5%ae%98%e4%bb%a5%e5%8f%8a%e7%a7%91%e5%ad%a6%e4%b8%8e%e6%88%98%e7%95%a5","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2021081218450040823","title":{"rendered":"\u5929\u6f14\u836f\u4e1a\u5ba3\u5e03\u4efb\u547d\u4ee3\u7406\u9996\u5e2d\u533b\u5b66\u5b98\u4ee5\u53ca\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u65b0\u6210\u5458"},"content":{"rendered":"<p><p><span class=\"xn-subheadline\">&#8211; \u5168\u7403\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u4e13\u5bb6\u56e2\u961f\u52a0\u5165\uff0c\u4e3a\u516c\u53f8\u53d8\u9769\u6027\u4e34\u5e8a\u7ba1\u7ebf\u5f00\u53d1\u8d4b\u80fd &#8211;<\/span><\/p>\n<p>\u4e2d\u56fd\u82cf\u5dde\u548c\u7f8e\u56fd\u65e7\u91d1\u5c712021\u5e748\u670812\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u5929\u6f14\u836f\u4e1a\uff08\u4ee5\u4e0b\u7b80\u79f0\u201c\u516c\u53f8\u201d\u6216\u201c\u5929\u6f14\u201d\uff09\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aADAG\uff09\u662f\u4e00\u5bb6\u5e73\u53f0\u9a71\u52a8\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u65b0\u578b\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u7684\u53d1\u73b0\u4e0e\u5f00\u53d1\u3002\u516c\u53f8\u4eca\u65e5\u5ba3\u5e03\uff0c\u4efb\u547d\u4ee3\u7406\u9996\u5e2d\u533b\u5b66\u5b98\u548c\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\uff08SAB\uff09\u65b0\u6210\u5458\u3002\u4ed6\u4eec\u5206\u522b\u662f\uff1aSteven Fischkoff\u533b\u5b66\u535a\u58eb<span id=\"spanHghlt92a5\">\uff0c<\/span>Stanley Frankel\u533b\u5b66\u535a\u58eb\uff0cFACP \uff0c\u4e0eRobert Spiegel \u533b\u5b66\u535a\u58eb<span id=\"spanHghlt08f8\">\uff0c<\/span>FACP\u3002<\/p>\n<p>\u201c\u6211\u4eec\u5341\u5206\u8363\u5e78\u80fd\u4e0e\u8fd9\u6837\u4e00\u4e2a\u5728\u836f\u7269\u5f00\u53d1\u9886\u57df\u5353\u6709\u5efa\u6811\u7684\u4e13\u5bb6\u56e2\u961f\u4e00\u8d77\u52aa\u529b\uff0c\u81f4\u529b\u4e8e\u4e3a\u5168\u7403\u80bf\u7624\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u53d8\u9769\u6027\u7597\u6cd5\u3002\u201d\u5929\u6f14\u8054\u5408\u521b\u59cb\u4eba\u3001\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u957f\u7f57\u57f9\u5fd7\u535a\u58eb\u8868\u793a\uff0c\u201c\u4ed6\u4eec\u66fe\u4f5c\u4e3a\u5148\u9a71\u9886\u5bfc\u8fc7\u6700\u65e9\u7684\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u4e34\u5e8a\u5f00\u53d1\uff0c\u800c\u4ed6\u4eec\u7684\u6218\u7565\u89c6\u91ce\u5c06\u4e3a\u5929\u6f14\u9879\u76ee\u7684\u5168\u7403\u5f00\u53d1\u613f\u666f\u8d4b\u80fd\uff0c\u6700\u5927\u9650\u5ea6\u5730\u53d1\u6325\u6211\u4eec\u5f3a\u5927\u4ea7\u54c1\u7ba1\u7ebf\u7684\u6f5c\u529b\u3002\u6211\u4eec\u5f88\u5e78\u8fd0\u80fd\u4e0e\u8fd9\u4e9b\u5f00\u62d3\u8005\u5408\u4f5c\uff0c\u5229\u7528\u6211\u4eec\u521b\u65b0\u7684\u6297\u4f53\u6280\u672f\u5e73\u53f0\uff0c\u5f15\u9886\u65b0\u4e00\u4ee3\u80bf\u7624\u514d\u75ab\u836f\u7269\u7684\u5f00\u53d1\u3002\u201d<\/p>\n<p>\u65b0\u7684\u4efb\u547d\u5982\u4e0b\uff1a<\/p>\n<p><b><span class=\"xn-person\">Steven Fischkoff<\/span><\/b><b>\uff0c\u533b\u5b66\u535a\u58eb<\/b>&nbsp;\u2013&nbsp;Fischkoff \u535a\u58eb\u662f\u5929\u6f14\u836f\u4e1a\u7684\u4ee3\u7406\u9996\u5e2d\u533b\u5b66\u5b98\uff0c\u4e5f\u662f\u5929\u6f14\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u7684\u6210\u5458\u3002\u4f5c\u4e3a\u4e00\u540d\u83b7\u5f97\u8ba4\u8bc1\u7684\u533b\u5b66\u80bf\u7624\u5b66\u5bb6\uff0cFischkoff \u535a\u58eb\u5df2\u5728\u5236\u836f\u884c\u4e1a\u6df1\u801530\u5e74\u3002\u6b64\u524d\u5728Medarex\u5de5\u4f5c\u671f\u95f4\uff0cFischkoff\u535a\u58eb\u8d1f\u8d23Yervoy<sup>&reg;<\/sup>\uff08\u4f0a\u5339\u5355\u6297\uff09\u7684\u4e34\u5e8a\u7814\u53d1\u3002\u4f0a\u5339\u5355\u6297\u662f\u9996\u4e2a\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\uff0c\u4e14\u662f\u8fc4\u4eca\u4e3a\u6b62\u552f\u4e00\u88abFDA\u6279\u51c6\u7684\u6297CTLA-4\u4ea7\u54c1\u3002\u5728Knoll\u5236\u836f\u548c\u7f8e\u56fd\u96c5\u57f9\u4efb\u804c\u671f\u95f4\uff0cFischkoff\u535a\u58eb\u66fe\u6210\u529f\u9886\u5bfc\u5168\u7403\u6700\u7545\u9500\u7684\u836f\u54c1Humira<sup>&reg;<\/sup>\uff08\u963f\u8fbe\u6728\u5355\u6297\uff09\u4eceI\u671f\u4e34\u5e8a\u8bd5\u9a8c\u81f3\u6700\u7ec8\u63d0\u4ea4\u4e0a\u5e02\u7533\u8bf7\uff0c\u5e76\u5728\u7f8e\u56fd\u548c\u6b27\u76df\u83b7\u5f97\u6279\u51c6\u3002<\/p>\n<p><b><span class=\"xn-person\">Stanley Frankel<\/span><\/b><b>\uff0c\u533b\u5b66\u535a\u58eb\uff0c<\/b><b>FACP<\/b>&nbsp;\u2013 Frankel \u535a\u58eb\u4f5c\u4e3a\u8840\u6db2\u80bf\u7624\u5b66\u5bb6\u52a0\u5165\u5929\u6f14\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u3002Frankel\u535a\u58eb\u5728\u5236\u836f\u884c\u4e1a\u5de5\u4f5c20\u4f59\u5e74\uff0c\u5728\u80bf\u7624\u514d\u75ab\u5b66\u548c\u7ec6\u80de\u7597\u6cd5\u7684\u7814\u7a76\u3001\u4e34\u5e8a\u7814\u53d1\u548c\u5546\u4e1a\u5316\u7b49\u65b9\u9762\u62e5\u6709\u5e7f\u6cdb\u7684\u5b66\u672f\u53ca\u884c\u4e1a\u7ecf\u9a8c\u3002\u4ed6\u66fe\u62c5\u4efb\u65b0\u57fa\u533b\u836f\u514d\u75ab\u80bf\u7624\u7684\u526f\u603b\u88c1\uff0c\u8d1f\u8d23\u4e0eMedImmune\/\u963f\u65af\u5229\u5eb7\u57fa\u4e8eImfinzi<sup>&reg;<\/sup>\uff08\u5ea6\u4f10\u5229\u5c24\u5355\u6297\uff09\u7684\u4e34\u5e8a\u5f00\u53d1\u5408\u4f5c\u3001\u65b0\u57fa\u8054\u5408\u767e\u6d4e\u795e\u5dde\u57fa\u4e8e\u767e\u6cfd\u5b89<sup>&reg;<\/sup>\uff08\u66ff\u96f7\u5229\u73e0\u5355\u6297\uff09\u7684\u4e34\u5e8a\u5f00\u53d1\u5408\u4f5c\uff0c\u4ee5\u53ca\u4e0eJuno Therapeutics\u57fa\u4e8e\u7ec6\u80de\u7597\u6cd5\u7684\u5f00\u53d1\u5408\u4f5c\u3002\u5728\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u6536\u8d2d\u65b0\u57fa\u4e4b\u540e\uff0c\u4ed6\u66fe\u62c5\u4efb\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u5168\u7403\u7ec6\u80de\u6cbb\u7597\u836f\u7269\u5f00\u53d1\u9ad8\u7ea7\u526f\u603b\u88c1\uff0c\u8d1f\u8d23Breyanzi<sup>&reg;<\/sup> <span id=\"spanHghlt30fd\">\uff08<\/span>lisocabtagene maraleucel<span id=\"spanHghlt6d0d\">\uff09<\/span>\u548cAbecma<sup>&reg;<\/sup><span id=\"spanHghlt9073\">\uff08<\/span>idecabtagene vicleucel<span id=\"spanHghltd77f\">\uff09<\/span>\u7684\u7533\u62a5\u4e0e\u5f00\u53d1\u3002\u6b64\u524d\uff0c\u4ed6\u8fd8\u66fe\u4f5c\u4e3aMicromet\u4e34\u5e8a\u5f00\u53d1\u526f\u603b\u88c1\uff0c\u8d1f\u8d23\u516c\u53f8\u5305\u62ec\u53cc\u7279\u5f02\u6027\u6297\u4f53Blincyto<sup>&reg;<\/sup>\uff08<span id=\"spanHghlt37cc\">\u500d\u6797\u59a5\u83ab\u53cc\u6297<\/span>\uff09\u5728\u5185\u7684\u5404\u9879\u7814\u53d1\u3002Frankel \u535a\u58eb\u76ee\u524d\u662fCytovia Therapeutics\u7684\u9996\u5e2d\u533b\u5b66\u5b98\uff0c\u4ee5\u53caPrecision Biosciences\u7684\u975e\u6267\u884c\u8463\u4e8b\u3002\u53e6\u5916\uff0c\u4ed6\u662fSutro Biopharma\u3001Immunai\u548cMinerva Biotechnologies\u7684\u79d1\u5b66\u987e\u95ee\u59d4\u5458\u4f1a\u6210\u5458\u3002Frankel \u535a\u58eb\u4e5f\u662f\u7ebd\u7ea6\u54e5\u4f26\u6bd4\u4e9a\u5927\u5b66\u74e6\u683c\u6d1b\u65af\u5185\u79d1\u548c\u5916\u79d1\u533b\u5b66\u9662\uff08Vagelos College of Physicians and Surgeons\uff09\u7684\u517c\u804c\u526f\u6559\u6388\u3002<\/p>\n<p><b><span class=\"xn-person\">Robert Spiegel<\/span><\/b><b>\uff0c\u533b\u5b66\u535a\u58eb\uff0c<\/b><b>FACP<\/b>&nbsp;\u2013 Spiegel \u535a\u58eb\u4f5c\u4e3a\u80bf\u7624\u533b\u5b66\u4e13\u5bb6\u52a0\u5165\u5929\u6f14\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u3002Spiegel\u535a\u58eb\u62e5\u6709\u8d85\u8fc730\u5e74\u7684\u751f\u7269\u5236\u836f\u9886\u57df\u4e34\u5e8a\u7814\u53d1\u548c\u8fd0\u8425\u7b49\u76f8\u5173\u5de5\u4f5c\u7ecf\u9a8c\uff0c\u5e76\u662f\u591a\u5bb6\u98ce\u9669\u6295\u8d44\u548c\u79c1\u52df\u80a1\u6743\u516c\u53f8\u7684\u987e\u95ee\u3002Spiegel\u535a\u58eb\u5728\u7f8e\u56fd\u56fd\u7acb\u536b\u751f\u7814\u7a76\u9662<span id=\"spanHghltcdbb\">\uff08<\/span>National Institutes of Health<span id=\"spanHghlt5614\">\uff09<\/span>\u83b7\u5f97\u533b\u5b66\u80bf\u7624\u5b66\u5956\u5b66\u91d1\u540e\uff0c\u62c5\u4efb\u4e86\u7ebd\u7ea6\u5927\u5b66\u764c\u75c7\u4e2d\u5fc3<span id=\"spanHghlt1730\">\uff08<\/span>NYU Cancer Center<span id=\"spanHghltbe1d\">\uff09<\/span>\u8f6c\u5316\u533b\u5b66\u79d1\u4e3b\u4efb\u3002\u968f\u540e\u4ed6\u4f5c\u4e3a\u9996\u4f4d\u80bf\u7624\u4e34\u5e8a\u9879\u76ee\u603b\u76d1\uff0c\u5728\u5148\u7075\u8446\u96c5\u4efb\u804c\u957f\u8fbe25\u4f59\u5e74\uff0c\u5e76\u5728\u540e\u671f\u62c5\u4efb\u4e86\u4e00\u7cfb\u5217\u9ad8\u7ea7\u7ba1\u7406\u804c\u4f4d\uff0c\u5305\u62ec\u9996\u5e2d\u533b\u5b66\u5b98\u3002\u4ed6\u8fd8\u66fe\u9886\u5bfc\u4e86Temodar<sup>&reg;<\/sup>\uff08\u66ff\u83ab\u5511\u80fa\uff09\u548cRemicade<sup>&reg;<\/sup>\uff08\u82f1\u592b\u5229\u6614\u5355\u6297\uff09\u7684\u5f00\u53d1\uff0c\u5e76\u53c2\u4e0e\u63d0\u4ea4\u4e86\u4e09\u5341\u591a\u4e2a\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Applications\uff09\u4e14\u6700\u7ec8\u83b7FDA\u6279\u51c6\u3002&nbsp;Spiegel \u535a\u58eb\u5e38\u5e74\u62c5\u4efb\u884c\u4e1a\u987e\u95ee\uff0c\u5e76\u5728\u591a\u5bb6\u751f\u7269\u533b\u836f\u516c\u53f8\u7684\u79d1\u5b66\u987e\u95ee\u59d4\u5458\u4f1a\u548c\u8463\u4e8b\u4f1a\u4efb\u804c\u3002<\/p>\n<p>\u516c\u53f8\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u7531\u591a\u4f4d\u5728\u80bf\u7624\u514d\u75ab\u9886\u57df\u4f5c\u51fa\u91cd\u8981\u8d21\u732e\u7684\u79d1\u5b66\u5bb6\u53ca\u4e34\u5e8a\u4e13\u5bb6\u7ec4\u6210\uff0c\u4ed6\u4eec\u5c06\u4e0e\u5929\u6f14\u7ba1\u7406\u56e2\u961f\u53ca\u5176\u4ed6\u4e34\u5e8a\u7814\u7a76\u8005\u7d27\u5bc6\u534f\u4f5c\uff0c\u4e3a\u516c\u53f8\u53d8\u9769\u6027\u7814\u53d1\u7ba1\u7ebf\u7684\u5168\u7403\u5f00\u53d1\u63d0\u4f9b\u6218\u7565\u652f\u6301\u3002<\/p>\n<p>\u5982\u9700\u4e86\u89e3SAB\u6210\u5458\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee:<br \/><a target=\"_blank\" href=\"https:\/\/www.adagene.com\/about\/key-advisors\/\" rel=\"nofollow noopener\">https:\/\/www.adagene.com\/about\/key-advisors\/<\/a><\/p>\n<p>\u5173\u4e8e\u5929\u6f14\u836f\u4e1a<\/p>\n<p>\u5929\u6f14\u836f\u4e1a\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aADAG\uff09\u662f\u5e73\u53f0\u9a71\u52a8\u5e76\u62e5\u6709<span id=\"spanHghlta91e\">\u81ea\u4e3b\u5e73\u53f0\u4ea7\u51fa<\/span>\u7684\u4e34\u5e8a\u4ea7\u54c1\u5f00\u53d1\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u516c\u53f8\u81f4\u529b\u4e8e\u53d1\u73b0\u5e76\u5f00\u53d1\u4ee5\u539f\u521b\u6297\u4f53\u4e3a\u57fa\u77f3\u7684\u65b0\u578b\u764c\u75c7\u514d\u75ab\u7597\u6cd5\u3002\u501f\u529b\u4e8e\u8ba1\u7b97\u751f\u7269\u5b66\u4e0e\u4eba\u5de5\u667a\u80fd\uff0c\u51ed\u501f\u5176\u5168\u7403\u9996\u521b\u7684\u4e09\u4f53\u5e73\u53f0\u6280\u672f\uff08\u65b0\u8868\u4f4d\u6297\u4f53NEObody&#x2122;\uff0c\u5b89\u5168\u6297\u4f53SAFEbody&#x2122;\u53ca\u5f3a\u529b\u6297\u4f53POWERbody&#x2122;\uff09\uff0c\u5929\u6f14\u836f\u4e1a\u5df2\u5efa\u7acb\u8d77\u805a\u7126\u4e8e\u65b0\u578b\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u7684\u72ec\u7279\u539f\u521b\u6297\u4f53\u4ea7\u54c1\u7ba1\u7ebf\uff0c\u4ee5\u89e3\u51b3\u5c1a\u672a\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u3002\u5929\u6f14\u5df2\u548c\u591a\u4e2a\u5168\u7403\u77e5\u540d\u5408\u4f5c\u4f19\u4f34\u8fbe\u6210\u4e86\u6218\u7565\u5408\u4f5c\u5173\u7cfb\uff0c\u5e76\u4ee5\u5176\u539f\u521b\u524d\u6cbf\u79d1\u6280\u4e3a\u5408\u4f5c\u4f19\u4f34\u7684\u65b0\u836f\u7814\u53d1\u8d4b\u80fd\u3002<\/p>\n<p>\u5982\u9700\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\uff1a<a target=\"_blank\" href=\"https:\/\/investor.adagene.com\/\" rel=\"nofollow noopener\">https:\/\/investor.adagene.com<\/a>\u3002 <\/p>\n<p><b>\u5b89\u5168\u6e2f\u58f0\u660e<\/b><\/p>\n<p>\u672c\u516c\u544a\u5305\u542b\u7f8e\u56fd\u8054\u90a6\u8bc1\u5238\u6cd5\u610f\u4e49\u4e0a\u7684\u524d\u77bb\u6027\u9648\u8ff0\uff0c\u5305\u62ec\u6709\u5173\u4e1a\u52a1\u8ba1\u5212\u7684\u9648\u8ff0\uff0c\u8fd9\u4e9b\u9648\u8ff0\u6d89\u53ca\u53ef\u80fd\u5bfc\u81f4\u5b9e\u9645\u7ed3\u679c\u4e0e\u8fd9\u4e9b\u524d\u77bb\u6027\u9648\u8ff0\u4e2d\u8868\u8fbe\u7684\u671f\u671b\u7ed3\u679c\u548c\u9884\u671f\u5b58\u5728\u91cd\u5927\u5dee\u5f02\u7684\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\u3002\u8fd9\u4e9b\u9648\u8ff0\u662f\u6839\u636e&nbsp;1995 \u5e74\u7f8e\u56fd\u79c1\u4eba\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848\u7684\u201c\u5b89\u5168\u6e2f\u201d\u6761\u6b3e\u4f5c\u51fa\u7684\u3002\u975e\u5386\u53f2\u4e8b\u5b9e\u7684\u9648\u8ff0\uff0c\u5305\u62ec\u5173\u4e8e\u516c\u53f8\u4fe1\u5ff5\u548c\u9884\u671f\u7684\u9648\u8ff0\uff0c\u5747\u4e3a\u524d\u77bb\u6027\u9648\u8ff0\u3002\u524d\u77bb\u6027\u9648\u8ff0\u6d89\u53ca\u56fa\u6709\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\uff0c\u8bb8\u591a\u56e0\u7d20\u53ef\u80fd\u5bfc\u81f4\u5b9e\u9645\u7ed3\u679c\u4e0e\u4efb\u4f55\u524d\u77bb\u6027\u9648\u8ff0\u4e2d\u5305\u542b\u7684\u7ed3\u679c\u5b58\u5728\u91cd\u5927\u5dee\u5f02\u3002\u5728\u67d0\u4e9b\u60c5\u51b5\u4e0b\uff0c\u524d\u77bb\u6027\u9648\u8ff0\u53ef\u4ee5\u901a\u8fc7\u8bf8\u5982\u201c\u53ef\u80fd\u201d\u3001\u201c\u5c06\u201d\u3001\u201c\u671f\u671b\u201d\u3001\u201c\u9884\u671f\u201d\u3001\u201c\u76ee\u6807\u201d\u3001\u201c\u76ee\u6807\u201d\u3001\u201c\u4f30\u8ba1\u201d\u3001\u201c\u6253\u7b97\u201d\u3001\u201c\u8ba1\u5212\u201d\u3001\u201c\u76f8\u4fe1\u201d\u3001\u201c\u6f5c\u529b\u201d\u3001\u201c\u7ee7\u7eed\u201d\u3001\u201c\u662f\/\u53ef\u80fd\u4f1a\u201d\u6216\u5176\u4ed6\u7c7b\u4f3c\u7684\u8868\u8fbe\u65b9\u5f0f\u3002\u6709\u5173\u8fd9\u4e9b\u548c\u5176\u4ed6\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u6216\u56e0\u7d20\u7684\u66f4\u591a\u4fe1\u606f\u5305\u542b\u5728\u516c\u53f8\u5411 SEC \u63d0\u4ea4\u7684\u6587\u4ef6\u4e2d\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u63d0\u4f9b\u7684\u6240\u6709\u4fe1\u606f\u5747\u622a\u81f3\u672c\u65b0\u95fb\u7a3f\u53d1\u5e03\u4e4b\u65e5\uff0c\u9664\u9002\u7528\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u672c\u516c\u53f8\u4e0d\u627f\u62c5\u4efb\u4f55\u66f4\u65b0\u6b64\u7c7b\u4fe1\u606f\u7684\u4e49\u52a1\u3002<\/p>\n<p>\u5185\u90e8\u8054\u7cfb\u4eba\uff1a<br \/><span class=\"xn-person\">Ami Knoefler<\/span><br \/>Adagene<br \/>650-739-9952<br \/><a target=\"_blank\" href=\"mailto:ir@adagene.com\" rel=\"nofollow noopener\">ir@adagene.com<\/a><\/p>\n<p>\u5916\u90e8\u8054\u7cfb\u4eba\uff1a<br \/><span class=\"xn-person\">Bruce Mackle<\/span><br \/>LifeSci Advisors<br \/>646-889-1200<br \/><a target=\"_blank\" href=\"mailto:bmackle@lifesciadvisors.com\" rel=\"nofollow noopener\">bmackle@lifesciadvisors.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8211; \u5168\u7403\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u4e13\u5bb6\u56e2\u961f\u52a0\u5165\uff0c\u4e3a\u516c\u53f8\u53d8\u9769\u6027\u4e34\u5e8a\u7ba1\u7ebf\u5f00\u53d1\u8d4b\u80fd &#8211; \u4e2d\u56fd\u82cf\u5dde\u548c\u7f8e\u56fd\u65e7\u91d1\u5c712021\u5e748\u670812\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u5929\u6f14\u836f\u4e1a\uff08\u4ee5\u4e0b\u7b80\u79f0\u201c\u516c\u53f8\u201d\u6216\u201c\u5929\u6f14\u201d\uff09\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aADAG\uff09\u662f\u4e00\u5bb6\u5e73\u53f0\u9a71\u52a8\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u65b0\u578b\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u7684\u53d1\u73b0\u4e0e\u5f00\u53d1\u3002\u516c\u53f8\u4eca\u65e5\u5ba3\u5e03\uff0c\u4efb\u547d\u4ee3\u7406\u9996\u5e2d\u533b\u5b66\u5b98\u548c\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\uff08SAB\uff09\u65b0\u6210\u5458\u3002\u4ed6\u4eec\u5206\u522b\u662f\uff1aSteven Fischkoff\u533b\u5b66\u535a\u58eb\uff0cStanley Frankel\u533b\u5b66\u535a\u58eb\uff0cFACP \uff0c\u4e0eRobert Spiegel \u533b\u5b66\u535a\u58eb\uff0cFACP\u3002 \u201c\u6211\u4eec\u5341\u5206\u8363\u5e78\u80fd\u4e0e\u8fd9\u6837\u4e00\u4e2a\u5728\u836f\u7269\u5f00\u53d1\u9886\u57df\u5353\u6709\u5efa\u6811\u7684\u4e13\u5bb6\u56e2\u961f\u4e00\u8d77\u52aa\u529b\uff0c\u81f4\u529b\u4e8e\u4e3a\u5168\u7403\u80bf\u7624\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u7684\u53d8\u9769\u6027\u7597\u6cd5\u3002\u201d\u5929\u6f14\u8054\u5408\u521b\u59cb\u4eba\u3001\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u957f\u7f57\u57f9\u5fd7\u535a\u58eb\u8868\u793a\uff0c\u201c\u4ed6\u4eec\u66fe\u4f5c\u4e3a\u5148\u9a71\u9886\u5bfc\u8fc7\u6700\u65e9\u7684\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u4e34\u5e8a\u5f00\u53d1\uff0c\u800c\u4ed6\u4eec\u7684\u6218\u7565\u89c6\u91ce\u5c06\u4e3a\u5929\u6f14\u9879\u76ee\u7684\u5168\u7403\u5f00\u53d1\u613f\u666f\u8d4b\u80fd\uff0c\u6700\u5927\u9650\u5ea6\u5730\u53d1\u6325\u6211\u4eec\u5f3a\u5927\u4ea7\u54c1\u7ba1\u7ebf\u7684\u6f5c\u529b\u3002\u6211\u4eec\u5f88\u5e78\u8fd0\u80fd\u4e0e\u8fd9\u4e9b\u5f00\u62d3\u8005\u5408\u4f5c\uff0c\u5229\u7528\u6211\u4eec\u521b\u65b0\u7684\u6297\u4f53\u6280\u672f\u5e73\u53f0\uff0c\u5f15\u9886\u65b0\u4e00\u4ee3\u80bf\u7624\u514d\u75ab\u836f\u7269\u7684\u5f00\u53d1\u3002\u201d \u65b0\u7684\u4efb\u547d\u5982\u4e0b\uff1a Steven Fischkoff\uff0c\u533b\u5b66\u535a\u58eb&nbsp;\u2013&nbsp;Fischkoff \u535a\u58eb\u662f\u5929\u6f14\u836f\u4e1a\u7684\u4ee3\u7406\u9996\u5e2d\u533b\u5b66\u5b98\uff0c\u4e5f\u662f\u5929\u6f14\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u7684\u6210\u5458\u3002\u4f5c\u4e3a\u4e00\u540d\u83b7\u5f97\u8ba4\u8bc1\u7684\u533b\u5b66\u80bf\u7624\u5b66\u5bb6\uff0cFischkoff \u535a\u58eb\u5df2\u5728\u5236\u836f\u884c\u4e1a\u6df1\u801530\u5e74\u3002\u6b64\u524d\u5728Medarex\u5de5\u4f5c\u671f\u95f4\uff0cFischkoff\u535a\u58eb\u8d1f\u8d23Yervoy&reg;\uff08\u4f0a\u5339\u5355\u6297\uff09\u7684\u4e34\u5e8a\u7814\u53d1\u3002\u4f0a\u5339\u5355\u6297\u662f\u9996\u4e2a\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\uff0c\u4e14\u662f\u8fc4\u4eca\u4e3a\u6b62\u552f\u4e00\u88abFDA\u6279\u51c6\u7684\u6297CTLA-4\u4ea7\u54c1\u3002\u5728Knoll\u5236\u836f\u548c\u7f8e\u56fd\u96c5\u57f9\u4efb\u804c\u671f\u95f4\uff0cFischkoff\u535a\u58eb\u66fe\u6210\u529f\u9886\u5bfc\u5168\u7403\u6700\u7545\u9500\u7684\u836f\u54c1Humira&reg;\uff08\u963f\u8fbe\u6728\u5355\u6297\uff09\u4eceI\u671f\u4e34\u5e8a\u8bd5\u9a8c\u81f3\u6700\u7ec8\u63d0\u4ea4\u4e0a\u5e02\u7533\u8bf7\uff0c\u5e76\u5728\u7f8e\u56fd\u548c\u6b27\u76df\u83b7\u5f97\u6279\u51c6\u3002 Stanley Frankel\uff0c\u533b\u5b66\u535a\u58eb\uff0cFACP&nbsp;\u2013 Frankel \u535a\u58eb\u4f5c\u4e3a\u8840\u6db2\u80bf\u7624\u5b66\u5bb6\u52a0\u5165\u5929\u6f14\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u3002Frankel\u535a\u58eb\u5728\u5236\u836f\u884c\u4e1a\u5de5\u4f5c20\u4f59\u5e74\uff0c\u5728\u80bf\u7624\u514d\u75ab\u5b66\u548c\u7ec6\u80de\u7597\u6cd5\u7684\u7814\u7a76\u3001\u4e34\u5e8a\u7814\u53d1\u548c\u5546\u4e1a\u5316\u7b49\u65b9\u9762\u62e5\u6709\u5e7f\u6cdb\u7684\u5b66\u672f\u53ca\u884c\u4e1a\u7ecf\u9a8c\u3002\u4ed6\u66fe\u62c5\u4efb\u65b0\u57fa\u533b\u836f\u514d\u75ab\u80bf\u7624\u7684\u526f\u603b\u88c1\uff0c\u8d1f\u8d23\u4e0eMedImmune\/\u963f\u65af\u5229\u5eb7\u57fa\u4e8eImfinzi&reg;\uff08\u5ea6\u4f10\u5229\u5c24\u5355\u6297\uff09\u7684\u4e34\u5e8a\u5f00\u53d1\u5408\u4f5c\u3001\u65b0\u57fa\u8054\u5408\u767e\u6d4e\u795e\u5dde\u57fa\u4e8e\u767e\u6cfd\u5b89&reg;\uff08\u66ff\u96f7\u5229\u73e0\u5355\u6297\uff09\u7684\u4e34\u5e8a\u5f00\u53d1\u5408\u4f5c\uff0c\u4ee5\u53ca\u4e0eJuno Therapeutics\u57fa\u4e8e\u7ec6\u80de\u7597\u6cd5\u7684\u5f00\u53d1\u5408\u4f5c\u3002\u5728\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u6536\u8d2d\u65b0\u57fa\u4e4b\u540e\uff0c\u4ed6\u66fe\u62c5\u4efb\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u5168\u7403\u7ec6\u80de\u6cbb\u7597\u836f\u7269\u5f00\u53d1\u9ad8\u7ea7\u526f\u603b\u88c1\uff0c\u8d1f\u8d23Breyanzi&reg; \uff08lisocabtagene maraleucel\uff09\u548cAbecma&reg;\uff08idecabtagene vicleucel\uff09\u7684\u7533\u62a5\u4e0e\u5f00\u53d1\u3002\u6b64\u524d\uff0c\u4ed6\u8fd8\u66fe\u4f5c\u4e3aMicromet\u4e34\u5e8a\u5f00\u53d1\u526f\u603b\u88c1\uff0c\u8d1f\u8d23\u516c\u53f8\u5305\u62ec\u53cc\u7279\u5f02\u6027\u6297\u4f53Blincyto&reg;\uff08\u500d\u6797\u59a5\u83ab\u53cc\u6297\uff09\u5728\u5185\u7684\u5404\u9879\u7814\u53d1\u3002Frankel \u535a\u58eb\u76ee\u524d\u662fCytovia Therapeutics\u7684\u9996\u5e2d\u533b\u5b66\u5b98\uff0c\u4ee5\u53caPrecision Biosciences\u7684\u975e\u6267\u884c\u8463\u4e8b\u3002\u53e6\u5916\uff0c\u4ed6\u662fSutro Biopharma\u3001Immunai\u548cMinerva Biotechnologies\u7684\u79d1\u5b66\u987e\u95ee\u59d4\u5458\u4f1a\u6210\u5458\u3002Frankel \u535a\u58eb\u4e5f\u662f\u7ebd\u7ea6\u54e5\u4f26\u6bd4\u4e9a\u5927\u5b66\u74e6\u683c\u6d1b\u65af\u5185\u79d1\u548c\u5916\u79d1\u533b\u5b66\u9662\uff08Vagelos College of Physicians and Surgeons\uff09\u7684\u517c\u804c\u526f\u6559\u6388\u3002 Robert Spiegel\uff0c\u533b\u5b66\u535a\u58eb\uff0cFACP&nbsp;\u2013 Spiegel \u535a\u58eb\u4f5c\u4e3a\u80bf\u7624\u533b\u5b66\u4e13\u5bb6\u52a0\u5165\u5929\u6f14\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u3002Spiegel\u535a\u58eb\u62e5\u6709\u8d85\u8fc730\u5e74\u7684\u751f\u7269\u5236\u836f\u9886\u57df\u4e34\u5e8a\u7814\u53d1\u548c\u8fd0\u8425\u7b49\u76f8\u5173\u5de5\u4f5c\u7ecf\u9a8c\uff0c\u5e76\u662f\u591a\u5bb6\u98ce\u9669\u6295\u8d44\u548c\u79c1\u52df\u80a1\u6743\u516c\u53f8\u7684\u987e\u95ee\u3002Spiegel\u535a\u58eb\u5728\u7f8e\u56fd\u56fd\u7acb\u536b\u751f\u7814\u7a76\u9662\uff08National Institutes of Health\uff09\u83b7\u5f97\u533b\u5b66\u80bf\u7624\u5b66\u5956\u5b66\u91d1\u540e\uff0c\u62c5\u4efb\u4e86\u7ebd\u7ea6\u5927\u5b66\u764c\u75c7\u4e2d\u5fc3\uff08NYU Cancer Center\uff09\u8f6c\u5316\u533b\u5b66\u79d1\u4e3b\u4efb\u3002\u968f\u540e\u4ed6\u4f5c\u4e3a\u9996\u4f4d\u80bf\u7624\u4e34\u5e8a\u9879\u76ee\u603b\u76d1\uff0c\u5728\u5148\u7075\u8446\u96c5\u4efb\u804c\u957f\u8fbe25\u4f59\u5e74\uff0c\u5e76\u5728\u540e\u671f\u62c5\u4efb\u4e86\u4e00\u7cfb\u5217\u9ad8\u7ea7\u7ba1\u7406\u804c\u4f4d\uff0c\u5305\u62ec\u9996\u5e2d\u533b\u5b66\u5b98\u3002\u4ed6\u8fd8\u66fe\u9886\u5bfc\u4e86Temodar&reg;\uff08\u66ff\u83ab\u5511\u80fa\uff09\u548cRemicade&reg;\uff08\u82f1\u592b\u5229\u6614\u5355\u6297\uff09\u7684\u5f00\u53d1\uff0c\u5e76\u53c2\u4e0e\u63d0\u4ea4\u4e86\u4e09\u5341\u591a\u4e2a\u65b0\u836f\u4e0a\u5e02\u7533\u8bf7\uff08New Drug Applications\uff09\u4e14\u6700\u7ec8\u83b7FDA\u6279\u51c6\u3002&nbsp;Spiegel \u535a\u58eb\u5e38\u5e74\u62c5\u4efb\u884c\u4e1a\u987e\u95ee\uff0c\u5e76\u5728\u591a\u5bb6\u751f\u7269\u533b\u836f\u516c\u53f8\u7684\u79d1\u5b66\u987e\u95ee\u59d4\u5458\u4f1a\u548c\u8463\u4e8b\u4f1a\u4efb\u804c\u3002 \u516c\u53f8\u79d1\u5b66\u4e0e\u6218\u7565\u987e\u95ee\u59d4\u5458\u4f1a\u7531\u591a\u4f4d\u5728\u80bf\u7624\u514d\u75ab\u9886\u57df\u4f5c\u51fa\u91cd\u8981\u8d21\u732e\u7684\u79d1\u5b66\u5bb6\u53ca\u4e34\u5e8a\u4e13\u5bb6\u7ec4\u6210\uff0c\u4ed6\u4eec\u5c06\u4e0e\u5929\u6f14\u7ba1\u7406\u56e2\u961f\u53ca\u5176\u4ed6\u4e34\u5e8a\u7814\u7a76\u8005\u7d27\u5bc6\u534f\u4f5c\uff0c\u4e3a\u516c\u53f8\u53d8\u9769\u6027\u7814\u53d1\u7ba1\u7ebf\u7684\u5168\u7403\u5f00\u53d1\u63d0\u4f9b\u6218\u7565\u652f\u6301\u3002 \u5982\u9700\u4e86\u89e3SAB\u6210\u5458\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee:https:\/\/www.adagene.com\/about\/key-advisors\/ \u5173\u4e8e\u5929\u6f14\u836f\u4e1a \u5929\u6f14\u836f\u4e1a\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aADAG\uff09\u662f\u5e73\u53f0\u9a71\u52a8\u5e76\u62e5\u6709\u81ea\u4e3b\u5e73\u53f0\u4ea7\u51fa\u7684\u4e34\u5e8a\u4ea7\u54c1\u5f00\u53d1\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u516c\u53f8\u81f4\u529b\u4e8e\u53d1\u73b0\u5e76\u5f00\u53d1\u4ee5\u539f\u521b\u6297\u4f53\u4e3a\u57fa\u77f3\u7684\u65b0\u578b\u764c\u75c7\u514d\u75ab\u7597\u6cd5\u3002\u501f\u529b\u4e8e\u8ba1\u7b97\u751f\u7269\u5b66\u4e0e\u4eba\u5de5\u667a\u80fd\uff0c\u51ed\u501f\u5176\u5168\u7403\u9996\u521b\u7684\u4e09\u4f53\u5e73\u53f0\u6280\u672f\uff08\u65b0\u8868\u4f4d\u6297\u4f53NEObody&#x2122;\uff0c\u5b89\u5168\u6297\u4f53SAFEbody&#x2122;\u53ca\u5f3a\u529b\u6297\u4f53POWERbody&#x2122;\uff09\uff0c\u5929\u6f14\u836f\u4e1a\u5df2\u5efa\u7acb\u8d77\u805a\u7126\u4e8e\u65b0\u578b\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u7684\u72ec\u7279\u539f\u521b\u6297\u4f53\u4ea7\u54c1\u7ba1\u7ebf\uff0c\u4ee5\u89e3\u51b3\u5c1a\u672a\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u3002\u5929\u6f14\u5df2\u548c\u591a\u4e2a\u5168\u7403\u77e5\u540d\u5408\u4f5c\u4f19\u4f34\u8fbe\u6210\u4e86\u6218\u7565\u5408\u4f5c\u5173\u7cfb\uff0c\u5e76\u4ee5\u5176\u539f\u521b\u524d\u6cbf\u79d1\u6280\u4e3a\u5408\u4f5c\u4f19\u4f34\u7684\u65b0\u836f\u7814\u53d1\u8d4b\u80fd\u3002 \u5982\u9700\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\uff1ahttps:\/\/investor.adagene.com\u3002 \u5b89\u5168\u6e2f\u58f0\u660e&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2021081218450040823\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-40823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/40823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=40823"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/40823\/revisions"}],"predecessor-version":[{"id":40824,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/40823\/revisions\/40824"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=40823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=40823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=40823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}